PM Modi will begin his three-city tour with a visit to the Zydus Cadila plant near Ahmedabad New Delhi: Prime Minister Narendra Modi will visit India’s major vaccine centers today to personally review the development of the coronavirus vaccine and the manufacturing process. The visit, Prime Minister Modi’s office said, …
Read More »
The Russian Direct Investment Fund (RDIF) and the Indian pharmaceutical company Hetero have agreed to produce in India more than 100 million doses a year of the Sputnik V covid vaccine in India, Russia’s sovereign wealth fund said. Production of the Russian covid vaccine is expected to start in early …
Read More »
Prime Minister Narendra Modi held a meeting on Friday to review India’s vaccination strategy in which issues such as prioritization of population groups and the technological platform for the deployment of the vaccine for the coronavirus were discussed. Modi tweeted that the meeting discussed important topics related to the progress …
Read More »
NEW DELHI: The CEO of vaccine maker Serum Institute of India, Adar Poonawalla, said Thursday that the Oxford Covid-19 vaccine should be available to healthcare workers and seniors around February 2021 and in April for the general public, and will have a maximum price of Rs 1,000 for two doses …
Read More »
NEW DELHI: The CEO of vaccine maker Serum Institute of India, Adar Poonawalla, said Thursday that the Oxford Covid-19 vaccine should be available to healthcare workers and seniors around February 2021 and in April for the general public, and will have a maximum price of Rs 1,000 for two doses …
Read More »
NEW DELHI: The global race to create vaccines against the novel coronavirus has entered a critical stretch, with Pfizer and Moderna releasing very promising final test data that has raised the hopes of nations struggling to combat the pandemic. Pfizer, which reported 95% efficiency, has now applied for early regulatory …
Read More »
Coronavirus Vaccine in India: Bharat Biotech, together with the Indian Council for Medical Research (ICMR) and the National Institute of Virology (NIV), is developing the indigenous coronavirus vaccine Covaxin. Coronavirus vaccine in India: Phase 3 human trials of the indigenous experimental vaccine Covaxin, a candidate for the coronavirus vaccine, are …
Read More »
By: Bloomberg | Updated: November 14, 2020 10:58:49 am Laboratory technicians handle capped vials as part of fill and pack testing for large-scale production and delivery of the University of Oxfords COVID-19 candidate vaccine. (Vincenzo Pinto / AFP / Getty Images via Bloomberg) The world’s largest vaccine maker is ramping …
Read More »
By: Reuters | New Delhi | Updated: November 5, 2020 3:51:40 pm Bharat Biotech developed Covaxin in collaboration with ICMR-National Institute of Virology. An Indian government-backed COVID-19 vaccine could be launched in February, months earlier than expected, as late-stage trials begin this month and studies so far have shown it …
Read More »
Written by Prabha Raghavan | New Delhi | Updated: October 24, 2020 7:52:13 am Covaxin: the country’s first indigenous vaccine is an inactivated one created from the infectious virus strain SARS-CoV-2. BHARAT BIOTECH, who has received approval for late stage human trials for its Covid vaccine candidate, it expects to …
Read More »